Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-01 Sale | 2026-07-01 9:30 pm | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 3,553,410 | $84.43 | $300,014,406 | 3,799,759 (Indirect) | View |
| 2026-06-23 Sale | 2026-06-23 9:56 pm | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 4,684,781 | $85.31 | $399,658,667 | 1,158,121 (Indirect) | View |
| 2026-05-11 Purchase | 2026-05-13 4:31 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 1,176,470 | $17 | $19,999,990 | 5,090,928 (Indirect) | View |
| 2026-03-31 Purchase | 2026-04-01 4:30 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 150,000 | $20 | $3,000,000 | 2,359,025 (Indirect) | View |
| 2026-03-31 Sale | 2026-03-31 9:30 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 7,000,000 | $34.66 | $242,620,000 | 5,542,832 (Indirect) | View |
| 2026-01-22 Sale | 2026-01-22 8:09 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 3,500,000 | $36.4 | $127,400,000 | 5,570,832 (Indirect) | View |
| 2026-01-22 Sale | 2026-01-22 8:07 pm | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 1,750,000 | $76.3 | $133,525,000 | 7,144,300 (Indirect) | View |
| 2025-12-04 Purchase | 2025-12-08 4:30 pm | CRESCENT BIOPHARMA INC. | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 1,360,000 | $13.41 | $18,237,600 | 4,516,006 (Indirect) | View |
| 2025-10-23 Purchase | 2025-10-27 4:30 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 454,545 | $22 | $9,999,990 | 3,914,458 (Indirect) | View |
| 2025-10-07 Purchase | 2025-10-09 4:15 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 316,219 | $19 | $6,008,161 | 2,209,025 (Indirect) | View |
| 2025-07-10 Purchase | 2025-07-14 4:30 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 2,777,777 | $9 | $24,999,993 | 9,003,418 (Indirect) | View |
| 2024-09-13 Purchase | 2024-09-17 9:00 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 1,600,000 | $18.75 | $30,000,000 | 3,445,813 (Indirect) | View |
| 2024-09-16 Purchase(A) | 2024-09-17 8:56 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 300,000 | $17 | $5,100,000 | 1,929,806 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-16 8:54 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 300,000 | $17 | $5,100,000 | 1,641,891 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-01 Conversion | 2026-07-01 9:30 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 3,596,051 | $0 | 3,799,759 (Indirect) | View |
| 2026-06-23 Conversion | 2026-06-23 9:56 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 683,347 | $0 | 1,158,121 (Indirect) | View |
| 2026-06-09 Option Award | 2026-06-11 8:04 pm | N/A 2036-06-09 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Director | 7,657 | $0 | 7,657 (Indirect) | View |
| 2026-06-09 Option Award | 2026-06-11 4:37 pm | N/A 2036-06-08 | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest IV L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 34,843 | $0 | 34,843 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-03 7:46 pm | N/A 2036-06-02 | CRESCENT BIOPHARMA INC. | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Harwin Peter Evan Kiselak Tomas Director 10% Owner | 11,050 | $0 | 11,050 (Indirect) | View |
| 2026-06-02 Option Award | 2026-06-03 4:45 pm | N/A 2036-06-01 | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Harwin Peter Evan Kiselak Tomas Director 10% Owner | 9,136 | $0 | 9,136 (Indirect) | View |
| 2026-05-27 Option Award | 2026-05-29 5:58 pm | N/A 2036-05-27 | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Kiselak Tomas Fairmount Healthcare Fund II L.P. Director | 8,026 | $0 | 8,026 (Indirect) | View |
| 2026-03-31 Conversion | 2026-03-31 9:30 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 7,028,000 | $0 | 5,542,832 (Indirect) | View |
| 2026-03-23 Option Award | 2026-03-25 6:03 pm | N/A 2036-03-23 | Damora Therapeutics Inc. | DMRA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest V L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 37,313 | $0 | 37,313 (Indirect) | View |
| 2026-02-09 Exercise | 2026-02-12 06:03 am | N/A N/A | Galecto Inc. | GLTO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest V L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 8,721,713 | $0 | 2,905,722 (Indirect) | View |
Ownership | 2025-11-17 9:48 pm | N/A N/A | Galecto Inc. | GLTO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest V L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 26,801,000 (Indirect) | View |
| 2025-10-06 Option Award | 2025-10-08 4:15 pm | N/A N/A | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest IV L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 1,333,126 | $9.14 | 5,408,541 (Indirect) | View |
| 2025-10-06 Option Award | 2025-10-08 4:15 pm | N/A N/A | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest IV L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 855,047 | $9.1399 | 5,408,541 (Indirect) | View |
| 2025-09-17 Option Award | 2025-09-19 5:33 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 333,340 | $15 | 3,705,262 (Indirect) | View |
| 2025-06-23 Option Award | 2025-06-23 6:48 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 9,023 | $0 | 9,023 (Indirect) | View |
Ownership | 2025-06-23 6:25 pm | N/A N/A | GLYCOMIMETICS INC | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 5,914,572 (Indirect) | View |
| 2025-06-17 Option Award | 2025-06-20 8:06 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 28,922 | $0 | 28,922 (Indirect) | View |
| 2025-06-10 Option Award | 2025-06-12 4:34 pm | N/A 2035-06-10 | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 18,500 | $0 | 18,500 (Indirect) | View |
| 2025-06-09 Exercise | 2025-06-11 5:00 pm | N/A 2025-06-10 | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 14,100 | $0 | 3,459,913 (Indirect) | View |
| 2025-06-10 Exercise | 2025-06-11 5:00 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 12,500 | $12.31 | 3,459,913 (Indirect) | View |
| 2025-06-09 Exercise | 2025-06-11 5:00 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 1,600 | $7.8 | 3,459,913 (Indirect) | View |
| 2025-06-02 Option Award | 2025-06-03 4:30 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Harwin Peter Evan Kiselak Tomas Director 10% Owner | 17,500 | $0 | 17,500 (Indirect) | View |
| 2025-05-29 Option Award | 2025-06-02 4:39 pm | N/A 2035-05-29 | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Harwin Peter Evan Kiselak Tomas Fairmount Healthcare Fund II L.P. Director | 50,000 | $0 | 50,000 (Indirect) | View |
| 2025-04-29 Option Award | 2025-05-01 6:16 pm | N/A 2035-04-29 | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 23,017 | $0 | 23,017 (Direct) | View |
Ownership | 2025-05-01 5:58 pm | N/A N/A | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 20,777,527 (Indirect) | View |
| 2024-11-19 Exercise | 2024-11-21 6:30 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160,160 | $0 | 3,371,922 (Indirect) | View |
| 2024-09-27 Other | 2024-10-01 8:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 62,146 | $0 | 2,762,837 (Indirect) | View |
| 2024-09-16 Conversion(A) | 2024-09-17 8:56 pm | N/A N/A | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 12,635,428 | $0 | 1,929,806 (Indirect) | View |
| 2024-09-12 Option Award(A) | 2024-09-17 8:56 pm | N/A 2034-09-11 | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 37,000 | $0 | 1,929,806 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-16 8:54 pm | N/A N/A | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 12,635,428 | $0 | 1,641,891 (Indirect) | View |
| 2024-09-12 Option Award | 2024-09-16 8:54 pm | N/A 2034-09-11 | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 37,000 | $0 | 1,641,891 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160 | $23,000 | 3,212,082 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 275,000 | $23 | 3,212,082 (Indirect) | View |
Ownership | 2024-09-12 9:41 pm | N/A N/A | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 1,592,806 (Indirect) | View |
Ownership | 2024-09-06 5:07 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 19,662,752 (Indirect) | View |
| 2024-06-10 Exercise | 2024-06-12 9:01 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 1,501,500 | $0 | 6,225,641 (Indirect) | View |
| 2024-06-05 Option Award | 2024-06-07 8:00 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 20,740 | $0 | 20,740 (Direct) | View |